Alovudine
Tools
Actions
General
Print/export
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by DePiep (talk | contribs) at 14:48, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H13F2N2O4 |
Molar mass | 244.22 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Alovudine was an antiviral agent being developed by Medivir, which was discontinued after a Phase II trial in 2005 due to toxicity. It was a DNA polymerase inhibitor.[1]
References
- ^ Georgopapadakou N. Discontinued drugs in 2005: anti-infectives. Expert Opin Investig Drugs. 2007 Jan;16(1):1-10. PMID 17155849
Baltimore I |
| ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatitis B (VII) | |||||||||||||||||||||
Multiple/general |
| ||||||||||||||||||||
|
Hepatitis C |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Hepatitis D | |||||||||
Picornavirus | |||||||||
Anti-influenza agents | |||||||||
Multiple/general |
| ||||||||
|
![]() | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Alovudine&oldid=713191747"